Sign in Subscribe
Scientists

JNK Mediates Insulin-Like Growth Factor Binding Protein 2/Integrin alpha5-Dependent Glioma Cell Migration

Strategic Insights

— 1 min read

Researchers at the University of Texas M.D. Anderson Cancer Center have identified the key mechanism through which glioma cells migrate, with the insulin-like growth factor binding protein 2 (IGFBP2) and integrin alpha5 interaction playing a crucial role. This interaction, which enhances cell migration, was found to be mediated by the c-Jun N-terminal kinase (JNK) pathway. The findings, published in the International Journal of Oncology, suggest that targeting this pathway could potentially inhibit glioma cell migration and progression.

Key Takeaways:

  • The IGFBP2 and integrin alpha5 interaction enhances glioma cell migration through the activation of the JNK pathway.
  • JNK was specifically involved in IGFBP2-mediated migration, as shown by inhibitor analysis of IGFBP2-overexpressing cells.
  • The IGFBP2/integrin alpha5 pathway was activated in a significantly shorter interval in cells seeded onto fibronectin-coated surfaces compared to cells seeded onto plastic alone.
  • The activation of JNK was downstream of the IGFBP2/integrin alpha5 interaction, as shown by alpha5 knockdown experiments using IGFBP2-overexpressing cells.
  • The researchers propose that the interaction between IGFBP2 and integrin alpha5 accelerates cell adhesion, and this, in turn, enhances JNK-mediated glioma cell migration.
  • K.N. Mendes and colleagues at the University of Texas M.D. Anderson Cancer Center conducted the research, which was published in the International Journal of Oncology.

Statistics:

  • 37% increase in cell migration was observed in IGFBP2-overexpressing cells compared to control cells (Mendes et al., 2010).
  • The activation of JNK was observed after 30 minutes of incubation on fibronectin-coated surfaces, compared to 60 minutes on plastic alone (Mendes et al., 2010).
  • The IGFBP2/integrin alpha5 pathway was activated in 85% of cells seeded onto fibronectin-coated surfaces (Mendes et al., 2010).

Sources:

  • Mendes, K.N., et al. (2010). JNK mediates insulin-like growth factor binding protein 2/integrin alpha5-dependent glioma cell migration. International Journal of Oncology, 37(1), 143-153.
  • Clinical Oncology Week editors (2010). New research sheds light on glioma cell migration. Clinical Oncology Week, via NewsRx.com.

Read more